Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Clinical Epigenetics|June 19, 2012
Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemiaChristoph Oing, Edgar Jost, Edgar Dahl, et al.
Cancers|September 23, 2022
White Paper: Mimetics of Class 2 Tumor Suppressor Proteins as Novel Drug Candidates for Personalized Cancer TherapyEdgar Dahl, Sophia Villwock, Peter Habenberger, et al.
Epigenetics|August 6, 2014
Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator phenotypeVera Kloten, Michael Rose, Sophie Kaspar, et al.
BMC Cancer|December 4, 2014
Epigenetic inactivation of ST6GAL1 in human bladder cancerPia Antony, Michael Rose, Axel Heidenreich, et al.
Breast Cancer Research : BCR|October 2, 2008
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumoursJürgen Veeck, Nuran Bektas, Arndt Hartmann, et al.
Molecular Cancer|November 8, 2008
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerJürgen Veeck, Erik Noetzel, Nuran Bektas, et al.
Plos One|March 11, 2020
Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotypeAlbert Rübben, Renate Ursula Wahl, Thomas Eggermann, et al.
Carcinogenesis|March 22, 2008
Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosisJürgen Veeck, Cordelia Geisler, Erik Noetzel, et al.
BMC Cancer|April 11, 2006
Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignanciesMenelaos Zafrakas, Beate Petschke, Andreas Donner, et al.
Breast Cancer Research : BCR|June 17, 2009
Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancerFrank Wiesmann, Jürgen Veeck, Oliver Galm, et al.
Pageof 14